| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/03/2004 | US6770797 Inducing prolonged in vivo gene expression in a mammal for inhibiting alzheimer's disease associated neuronal cell death |
| 08/03/2004 | US6770750 Nucleotide sequences coding polypeptide for use and treatment of microorganismal infections |
| 08/03/2004 | US6770749 Nucleic acids coding for both a and b chains of human p53, human leukocyte antigen(hla) restricted murine t-cell receptor (tcr); transformed cd8+ cytotoxic t lymphocytes for immunotherapy of tumors that over-express p53 |
| 08/03/2004 | US6770746 Chemical modification of proteins to improve biocompatibility and bioactivity |
| 08/03/2004 | US6770745 Common gamma chain blocking agents |
| 08/03/2004 | US6770744 Genetically engineered antihemophilic factor for use in the treatment of blood disorders |
| 08/03/2004 | US6770743 Genetic engineered drug |
| 08/03/2004 | US6770742 Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer |
| 08/03/2004 | US6770739 Elimination of protein kinase (pka) dependence of the chloride channel by means of deletion of neg2 from the cystic fibrosis transmembrane conductance regulator (cftr) |
| 08/03/2004 | US6770738 Used to modulate protein activity through, for example, transcription arrest, transcription initiation, and site specific cleavage of nucleic acids |
| 08/03/2004 | US6770631 Non-identical genes and their application in improved molecular adjuvants |
| 08/03/2004 | US6770626 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors |
| 08/03/2004 | US6770479 Vaccines for bacterial toxins from bacillus anthracis |
| 08/03/2004 | US6770474 Nucleotide sequences for use in diagnosis and treatment of viral, liver, nervous system, autoimmune and tumoral diseases |
| 08/03/2004 | US6770473 Wild-type and mutant human kinase interacting strathmin (hkis) polypeptides along with cyclin kinase inhibitors containing mutations that prevent their inhibition with serine/ threonine kinases |
| 08/03/2004 | US6770462 Methods for producing modified nucleic acid molecules |
| 08/03/2004 | US6770461 High bone mass gene of 11q13.3 |
| 08/03/2004 | US6770460 Fusion protein having epitopes of at least two of the autoantigens glutamic acid decarboxylase (gad65), islet cell antigen (ia2) and preproinsulin (ppins) wherenin said epitopes are connected with a linker peptide |
| 08/03/2004 | US6770458 Tgf- transforming growth factor |
| 08/03/2004 | US6770457 Process of purifying angiogenesis inhibitors |
| 08/03/2004 | US6770456 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 08/03/2004 | US6770455 Preparation, use and medicaments containing ribonucleotide polypeptides or their molecular-biological equivalent structures and/or parts and/or derivatives |
| 08/03/2004 | US6770449 Methods of assaying receptor activity and constructs useful in such methods |
| 08/03/2004 | US6770448 Fluorescent amyloid Aβ peptides and uses thereof |
| 08/03/2004 | US6770446 Cell systems having specific interaction of peptide binding pairs |
| 08/03/2004 | US6770444 Methods of identifying or screening for agents that binds the Ob-Re |
| 08/03/2004 | US6770442 Methods for modulating the solubility of synthetic polymers |
| 08/03/2004 | US6770438 Oncogene, oncoprotein; associated with tumorigenicity; mn genes from cellular component of matu, a quasi viral agent derived from a human mammary tumor |
| 08/03/2004 | US6770435 Set of contiguous and partially overlapping cdna sequences and polypeptides encoded thereby; useful for the detecting, diagnosing, staging, monitoring, prognosticating, in vivo imaging, preventing or treating conditions like breast cancer |
| 08/03/2004 | US6770284 Polypeptides and polynucleotides BASB040 from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 08/03/2004 | US6770283 DNA expression systems based on alphaviruses |
| 08/03/2004 | US6770281 B-cell epitope peptides of HSP 65 |
| 08/03/2004 | US6770278 To treat exercise induced pulmonary hemorrhage in horses |
| 08/03/2004 | US6770275 Isolated live, attenuated apx toxin-producing actinobacillus pleuropneumoniae having a deletion in two apx activator genes wherein does not produce two functional apx activator proteins, but two apx toxins in a non-activated form |
| 08/03/2004 | US6770272 Treatment of diabetes |
| 08/03/2004 | CA2318490C A novel gene for controlling leaf shapes |
| 08/03/2004 | CA2160696C Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 08/03/2004 | CA2144317C Hepatitis a virus vaccines |
| 08/03/2004 | CA2142599C Method for diagnosing and monitoring sepsis |
| 08/03/2004 | CA2089111C Smooth muscle mitogen and isolated dna coding therefor |
| 07/29/2004 | WO2004063750A1 Method of evaluating hair growth-promoting activity |
| 07/29/2004 | WO2004063719A2 Method to form a protein microarray system |
| 07/29/2004 | WO2004063379A1 Zea mays revoluta/if1 homolog genes and uses thereof |
| 07/29/2004 | WO2004063378A2 Polypeptides involved in floral development and genes encoding the same |
| 07/29/2004 | WO2004063376A1 Method for preparing recombinant heterocarpine |
| 07/29/2004 | WO2004063371A1 Protein complex, process for producing the same and use thereof |
| 07/29/2004 | WO2004063366A1 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 07/29/2004 | WO2004063362A2 Cell cycle progression proteins |
| 07/29/2004 | WO2004063361A1 Human calcium transporter 1 gene, method of screening calcium absorption regulator and calcium absorption promoter |
| 07/29/2004 | WO2004063358A1 Method for the genetic modification of organisms of the genus blakeslea, corresponding organisms, and the use of the same |
| 07/29/2004 | WO2004063354A2 Compositions and methods for characterizing and regulating wnt pathways |
| 07/29/2004 | WO2004063349A2 Lysozyme transgenic ungulates |
| 07/29/2004 | WO2004063341A2 Hematopoietic stem cell niche cells |
| 07/29/2004 | WO2004063340A2 Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061,17662,1468,12282, 6350, 9035,1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123,12788,17729, 65552,1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 4 |
| 07/29/2004 | WO2004063332A2 Cancer related genes |
| 07/29/2004 | WO2004063327A2 F11 receptor(f11r) antagonists as therapeutic agents |
| 07/29/2004 | WO2004063326A2 Proteorhodopsin mutants with improved optical characteristics |
| 07/29/2004 | WO2004063324A2 Canine gene microarrays |
| 07/29/2004 | WO2004063226A2 Novel fibrillin-like polypeptides |
| 07/29/2004 | WO2004063225A2 Novel fibulin-like polypeptides |
| 07/29/2004 | WO2004063224A1 Novel lysophosphatidic acid receptor |
| 07/29/2004 | WO2004063223A2 Notch-like polypeptides |
| 07/29/2004 | WO2004063222A2 Novel preadipocyte factor-1-like polypeptides |
| 07/29/2004 | WO2004063221A1 Metastin derivative and use thereof |
| 07/29/2004 | WO2004063220A1 Hydrophilic recombinant gp100 protein and uses thereof for immunotherapy |
| 07/29/2004 | WO2004063219A1 Defensin protins |
| 07/29/2004 | WO2004063218A1 Obesity-related genes |
| 07/29/2004 | WO2004063214A2 Antibodies that specifically recognize sumo-conjugated proteins |
| 07/29/2004 | WO2004063212A2 Organic compounds with biological action as thrombin inhibitors and use therof |
| 07/29/2004 | WO2004063153A2 Low efficacy gonadotropin agonists and antagonists |
| 07/29/2004 | WO2004062689A1 Stabilized aqueous compositions comprising tissue factor pathway inhibitor (tfpi) or tissue factor pathway inhibitor variant |
| 07/29/2004 | WO2004062619A2 SOLUBLE FcϜR FUSION PROTEINS AND METHODS OF USE THEREOF |
| 07/29/2004 | WO2004062597A2 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | WO2004062584A2 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 07/29/2004 | WO2004062583A2 Vaccine and method for preventing biofilm formation |
| 07/29/2004 | WO2004062578A2 Methods for reducing mortality associated with acute myocardial infarction |
| 07/29/2004 | WO2004062574A2 Improved linkers for radiopharmaceutical compounds |
| 07/29/2004 | WO2004062567A2 Arterivirus marker vaccine |
| 07/29/2004 | WO2004062556A2 Methods for preventing and treating alzheimer’s disease (ad) |
| 07/29/2004 | WO2004062478A2 Isolation and characterization of eca1, a gene overexpressed in endometrioid carcinomas of ovary and endometrium |
| 07/29/2004 | WO2004062366A2 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
| 07/29/2004 | WO2004052930A3 Targeting single epitopes |
| 07/29/2004 | WO2004052404A3 Glycogen synthase kinase-3 inhibitors |
| 07/29/2004 | WO2004050880A3 Insecticidal agent |
| 07/29/2004 | WO2004050111A3 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 07/29/2004 | WO2004048408A3 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
| 07/29/2004 | WO2004048402A3 A hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 07/29/2004 | WO2004046311A3 A method for the crystallization of human serum albumin |
| 07/29/2004 | WO2004045379A3 Biomarkers for intra-amniotic inflammation |
| 07/29/2004 | WO2004044001A3 Acetylated hmgb1 protein |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004039942A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 07/29/2004 | WO2004038025A3 Genes and proteins for the biosynthesis of the glycopeptide antibiotic a40926 |
| 07/29/2004 | WO2004037856A3 Plasmodium falciparum virulence factor var o |
| 07/29/2004 | WO2004037175A3 Compositions and methods for treating human papillomavirus-mediated disease |
| 07/29/2004 | WO2004035613A3 4-methylhexanoic kahalaide f compound |
| 07/29/2004 | WO2004028449A3 Azulene dimer-quenched, near-infrared fluorescent probes |
| 07/29/2004 | WO2004022104A3 Foxp2 and uses thereof |
| 07/29/2004 | WO2004020576A3 Glycosylated human granulocyte colony-stimulating factor (g-csf) isoform |
| 07/29/2004 | WO2004019856A3 Glycosylated human interferon alpha isoform |